Hormone-sensitive lipase (HSL) is a key enzyme of lipid metabolism and its control is therefore a target in the treatment of diabetes mellitus. Cultures of the Streptomyces species DSM 13381 have been shown to potently inhibit HSL. Ten inhibitors of HSL, termed cyclipostins, have been isolated from the mycelium of this microorganism and a further nine related compounds detected. Their structures were characterized by 2-D NMR experiments and by mass spectrometry and were found to comprise neutral cyclic enol phosphate esters with an Hormone-sensitive lipase (HSL), the rate-limiting enzyme of intracellular triglyceride hydrolysis, is a major determinant of fatty acid mobilization in adipose tissue as well as in other tissues1). It plays a pivotal role in lipid metabolism, overall energy homeostasis, and cellular events involving fatty acid signaling. Fatty acids stored in the form of triglycerides are the main source of energy in the absence of dietary substrates. Hydrolysis of triglycerides involves a sequence of three reactions and is catalyzed by two enzymes: HSL and monoglyceride lipase. HSL on its own is sufficient to catalyze the hydrolysis of tri-and diglycerides, but the participation of monoglyceride lipase is required to achieve complete hydrolysis of monoglycerides1,2). Lipolysis is a regulated event; it is controlled mainly by the activity of the sympathetic nervous system and counteracted by plasma insulin levels3).
In diabetes the normally balanced relationship between fats and glucose as metabolic fuels is disturbed. Fatty acids circulating in increased concentrations are metabolized in preference to glucose, while at the same time providing energy for excessive glucose production (gluconeogenesis), thereby resulting in raised glucose concentrations4). An elevated circulating free fatty acid concentration, a major feature of non-insulin-dependent or type II diabetes mellitus, is due to a dysregulation of adipose tissue function5). Because of its role in fatty acid mobilization, HSL is among the candidates for such dysregulation, and has been suggested as a target for the development of new antidiabetic drugs.
As a consequence, we have been investigating microbial cultures for the presence of possible inhibitors, and in fermentation solutions of Streptomyces sp. DSM 13381 we detected compounds that showed strong anti-HSL activity6,7). In this paper we describe these inhibitors, which we termed cyclipostins, their isolation from cultures of Streptomyces sp. DSM 13381, their structural characterization, and some biochemical properties. with a flow rate of 60ml/minute. The fractions containing mostly cyclipostins N, R, R2, and P2 were pooled, as were the later fractions containing cyclipostins P, S, T, and T2.
Preparative chromatographic separation of the individual constituents was in each case carried out by successive passage through 250/21 Nucleosil 100-5 C18 AB and 250/21 Nucleosil 100-7 C18 HD columns (both MachereyNagel, Duren, Germany), as the relative retention times on the solid supports were different. The columns were eluted with a gradient of 70 to 80% acetonitrile in 0.002% trifluoroacetic acid adjusted to pH 3.5 with dilute NMR Spectroscopy All NMR spectra were recorded on Bruker DRX 600 spectrometers operating at 600MHz (1H) and 150MHz (13C) Data were processed on an indigo2 station (Silicon Graphics) using Bruker XWINNMR software. DQF-COSY experiments were performed with a spectral width of 5ppm. Spectra were recorded with 1024 increments in t1 and 4096 complex data points in t2, with 8 transients averaged for each t1 value. For the HMQC8) spectra, 512 increments (16 scans) with 2048 complex data points in t2 were collected using a sweep width of 5ppm in the proton and 160ppm in the carbon dimension. The HMBC9) spectra were acquired with a sweep width of 5ppm in the proton and 200ppm in the carbon dimension. A total of 64 transients were averaged for each of 512 increments in t1, and 2048 complex points in t2 were recorded. A delay of 70 msec was used for the development of long range correlations.
Mass Spectrometry
High resolution measurements were obtained on a VG ZAB 2SEQ sector field instrument using a FAB or EI source. MS/MS experiments were generally conducted on a VG Bio-Q triple quadrupole mass spectrometer by loop injection of the sample into the ESI source (solvent These data indicate that the major portion of the lipolytic activity in the preparation is based on HSL and only minor portions (less than 3 and 30%, respectively) are due to contaminating lipoprotein lipase (sensitive toward NaCl) and monoacylglycerol hydrolase (resistant toward NaF).
Assay for HSL Activity
For the preparation of the substrates, a mixture of Table 1 . Structural formulae and some physicochemical data of the isolated cyclipostins.
* The HPLC procedure is described in the Experimental section.
The fatty alcohol side chain is attached at C1' to the ester oxygen atom of the phosphoric acid. in comparatively higher yields of up to 2mg/liter of cyclipostin P as the principal constituent, or 4g in 2000 liters. However, under these fermentation conditions, the more highly oxidized cyclipostins A-F (Fig. 1) are absent. Isolated from 2m3 of culture solution were 16mg cyclipostin N (oil), 1.3g of crystalline cyclipostin P, approx. 3g cyclipostin P2 (oil), 120mg of crystallized cyclipostin R, 80mg cyclipostin R2 (oil), 7mg cyclipostin S, 47mg cyclipostin T, and 44mg cyclipostin T2 (solid).
The more oxygen-poor cyclipostins N to T2 are of similar polarity to triglycerides, which meant they could be separated from the inhibitor-containing fractions only with difficulty. The content of these neutral lipids was Both NMR spectra and GC determinations revealed approx. 
Structural Elucidation by NMR
The structural elucidation of all compounds is based on the analyses of various 2D-NMR experiments including DQF-COSY18), HMQC8), and HMBC9) spectra. The unusual coupling patterns in the 1H spectra and the splitting Table 2 . Structural formulae and some physicochemical data of the detected, but not preparatively isolated cyclipostins.
The fatty alcohol side chain is attached at C1' to the ester oxygen atom of the phosphoric acid. The structures of cyclipostins A2 and Q3 were determined by NMR, those of B-E by GC-MS, and those of cyclipostins G, H, and Q by ESI-MS. of several signals in the 13C spectra indicated the presence in the molecule of a phosphorus center. The correlations in the DQF-COSY and HMBC spectra led us to deduce a bicyclic core structure, as was previously reported for the acetylcholinesterase inhibitor cyclophostin19), a major difference being that the O-methyl group of cyclophostin is replaced by various long-chain alkyl substituents. The chemical structure of the different side chains was deduced from correlations in the DQF-COSY and HMBC spectra, with the overall chain length (exact number of CH2 groups)
derived from the molecular weight. In the case of cyclipostin A, the position of the hydroxyl group was determined by MS fragmentation studies (see below). For cyclipostins S, T and T2, the signal of the methyl group C7 was missing; in these compounds the methyl substituent is replaced by an ethyl (S) or propyl group (T, T2), as demonstrated by correlations in the HMBC spectra and by the 13C/31P couplings (in all the cyclipostins C7 shows a1 3C/31P coupling constant of between 4.5 and 5.0Hz).
Mass Spectrometric Characterization of the Cyclipostins
Cyclipostins are easily ionized by ESI or FAB in the positive mode and their elemental compositions were determined using a high-resolution sector-field instrument (Table 5 ). For their structure elucidation, the protonated ions were subjected to collision-induced dissociations carried out using FTICR and/or triple quadrupole mass analyzers. The general fragmentation pattern of all the cyclipostins is similar (Scheme 1). By far the lowest energy path involves elimination of the alkyl side chain, yielding the bicyclic core 1. As expected for cyclic phosphatecontaining ions, the fragmentation of 1 is accompanied by extensive rearrangements, which renders further structural assignments impossible. However, it is possible to distinguish alkyl=Me from alkyl=Et, Pr on the basis of the relative fragment intensities (Table 2 ). For alkyl=Et, Pr, elimination of H3PO4 dominates, whereas for alkyl=Me, elimination of C2H2O, HPO3, H3PO4 and C7H6O2 occurs with almost equal frequency. Loss of H3PO4 presumably involves abstraction of a proton; this process is more difficult from a primary carbon than from a secondary carbon center, which explains the relatively low degree of elimination from alkyl=Me.
The lack of basic sites in the cyclipostin molecules means that spectra in the ESI-mode are weak and In all the oxidized cyclipostin derivatives, the oxidation position to the keto group indicates its location in the chain. This process is similar to a McLafferty rearrangement, except that a hydrogen atom is transferred to the neighboring basic phosphate group prior to cleavage (Scheme 2). On the basis of the transformations outlined in Scheme 2, a mixture of three components with oxo groups at C14 (cyclipostin F, 63%), C13 (cyclipostin G, 10%), and C12 (cyclipostin H, 27%) was identified. Alcohols were derivatized to improve their volatility prior to analysis. Silylation using N-methyl-N-(trimethylsilyl)trifluoracetamide (MSTFA) followed by GCMS was accompanied by breakdown of the bicyclic structure, with formation of the silylated alcohols 2.
However, we were able to establish unambiguously the reactions that occur either side of the hydroxy group with loss of an enol ether moiety. For example, fragmentation of 2a (554amu) on electron ionization gave fragments at m/z=497, 159, and 396amu, indicating that the oxidation site is C12 (Scheme 3). The GCMS chromatogram contained four species corresponding to the structure 2, with relative intensities of 83.1% (cyclipostins A and A2, hydroxy group at C12), 10.3% (cyclipostin B, C13), 6.3%
(cyclipostin C, C14), and 0.4% (cyclipostin E, C16). In summary, mass spectrometric high-resolution and fragmentation experiments give easy access to mainly four kinds of information on cyclipostins: (i) the molecular formula, (ii) the length of the alkyl side chain, (iii) the position of hydroxy and oxo groups in the side chain, and (iv) differentiation between R2=Me and R2=Et, Pr.
Biological Properties
As can be seen from the data shown in Table 7 , cyclipostins inhibit hormone-sensitive lipase at nanomolar concentrations. We observed reasonable coincidence of the IC50 values for inhibition of HSL (determined using both glyceryl trioleate and cholesteryl oleate as the substrate) in the cell-free assay system (Table 7) and for inhibition of HSL in intact isolated rat adipocytes, measured as release of either glycerol or fatty acids, the lipolysis products: the cyclipostins A, P, P2, and R inhibit the lipolysis in rat assay system, cyclipostins do not interfere with stimulation of lipolysis by adenosine deaminase and isoproterenol (Fig.   2 ). Furthermore, cyclipostins are able to completely block lipolysis (total glycerol and fatty acid release) from adipocytes in the basal (data not shown) and stimulated state (Fig. 2) . These data are strong evidence for direct inhibition of HSL rather than interruption of the signaling cascade leading to activation of HSL. The similar activity of the various cyclipostin components between inhibition of HSL in the cell-free and cellular systems and only moderate loss of potency in intact rat adipocytes compared with the partially purified rat HSL suggest that cyclipostins cross the plasma membrane with high efficiency. Efficient membrane transfer of cyclopostins would also explain the observation that inhibition of lipolysis in rat adipocytes by cyclipostins, as measured by the apparent IC50 values, was not enhanced by increasing the total incubation and assay time, as reflected in the approximately linear increments of glycerol release with time at each inhibitor concentration (Fig. 2) and the constancy in the calculated IC50 values for the different incubation times. Neither did the duration of preincubation of glyceryl trioleate with the cyclipostins (>5 minutes) prior to the start of the cleavage reaction have any significant effect on the cell-free assay system (data not given preincubated with the substrate glyceryl trioleate or cholesteryl oleate prior to initiation of the cleavage reaction by addition of partially purified rat HSL as described in the Experimental section. IC50 values were calculated from the fitted inhibition curves as the mean (n=4). 
